Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of InMed Pharmaceuticals Inc (NASDAQ: INM) was $2.98 for the day, down -10.24% from the previous closing price of $3.32. In other words, the price has decreased by -$10.24 from its previous closing price. On the day, 0.52 million shares were traded.
Ratios:
Our analysis of INM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.04 and its Current Ratio is at 3.49. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.06.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 31 ’24 when MANCINI ALEXANDRA DIANE JANET sold 240 shares for $0.18 per share. The transaction valued at 42 led to the insider holds 0 shares of the business.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.73 while its Price-to-Book (P/B) ratio in mrq is 0.51.
Stock Price History:
Over the past 52 weeks, INM has reached a high of $15.70, while it has fallen to a 52-week low of $1.72. The 50-Day Moving Average of the stock is 10.73%, while the 200-Day Moving Average is calculated to be -26.66%.
Shares Statistics:
A total of 1.21M shares are outstanding, with a floating share count of 0.17M. Insiders hold about 0.39% of the company’s shares, while institutions hold 52.16% stake in the company.
